Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18579324 | ARTICLES AND METHODS FOR PERFORMING ASSAYS | January 2024 | December 2024 | Allow | 11 | 1 | 1 | Yes | No |
| 18455397 | DIAGNOSTIC ASSAY METHODS USING ASSAY DEVICE HAVING MICROREACTOR | August 2023 | May 2024 | Allow | 9 | 1 | 0 | Yes | No |
| 18333596 | DEVICE AND METHOD FOR PATHOGEN DETECTION | June 2023 | April 2025 | Abandon | 22 | 3 | 0 | Yes | No |
| 18323723 | DIAGNOSTIC CARTRIDGE FOR IMMUNODIAGNOSIS AND DIAGNOSTIC DEVICE AND SYSTEM USING THE SAME | May 2023 | January 2026 | Allow | 32 | 0 | 0 | No | No |
| 18034448 | MODIFIED ELISA WITH HEMOGLOBIN CORRECTION APPARATUS AND METHODS THEREOF | April 2023 | January 2026 | Allow | 33 | 0 | 0 | No | No |
| 17786245 | SELECTIVE WHITE BLOOD CELL LYSIS FOR IMMUNOASSAY SYSTEMS | June 2022 | April 2024 | Allow | 22 | 2 | 0 | No | No |
| 17803387 | OPTICAL BIOMODULE FOR DETECTION OF DISEASES AT AN EARLY ONSET | June 2022 | December 2023 | Allow | 18 | 1 | 1 | Yes | No |
| 17777268 | TIME-RESOLVED FLUORESCENCE KIT FOR SYNCHRONOUSLY DETECTING 4,15-DIACETOXYSCIRPENOL, DEOXYNIVALENOL, AND T-2 TOXIN | May 2022 | June 2023 | Allow | 13 | 1 | 0 | No | No |
| 17744555 | DETECTION DEVICE, SAMPLE SOLUTION LOADING DEVICE, TEST STRIP LOADING BOARD AND TEST STRIP | May 2022 | March 2023 | Allow | 10 | 1 | 1 | No | No |
| 17590044 | MICROWELL ASSAY PLATE AND RELATED METHODS | February 2022 | January 2025 | Allow | 36 | 1 | 1 | No | No |
| 17567992 | Piezoelectric Plate Sensor and Uses Thereof | January 2022 | September 2025 | Allow | 45 | 0 | 0 | Yes | No |
| 17560430 | CATALYTIC SIGNAL ENHANCEMENT FOR LATERAL FLOW IMMUNOASSAYS | December 2021 | November 2025 | Allow | 47 | 0 | 0 | No | No |
| 17478595 | HOMOGENOUS ASSAY (II) | September 2021 | September 2022 | Allow | 12 | 1 | 0 | Yes | No |
| 17440368 | AUTOMATIC SYSTEM AND METHOD FOR TISSUE SECTIONING, STAINING, AND SCANNING | September 2021 | March 2025 | Allow | 42 | 0 | 2 | No | No |
| 17473672 | Sealed Lateral Flow Device | September 2021 | February 2026 | Allow | 53 | 1 | 0 | No | No |
| 17424304 | SINGLE CELL SELECTION AND ISOLATION | July 2021 | March 2026 | Allow | 56 | 1 | 2 | Yes | No |
| 17378671 | LIGHT MICROSCOPY CHIPS AND DATA ANALYSIS METHODOLOGY FOR QUANTITATIVE LOCALIZED SURFACE PLASMON RESONANCE (LSPR) BIOSENSING AND IMAGING | July 2021 | January 2026 | Allow | 54 | 1 | 0 | Yes | No |
| 17335605 | METHOD OF ISOLATING AND DETECTING EXOSOMAL BIOMARKERS OF GLIOBLASTOMA MALIGNANCY | June 2021 | October 2024 | Allow | 41 | 2 | 0 | No | No |
| 17317212 | SYSTEM FOR EVALUATING URINE FOR THE PRESENCE OR ABSENCE OF PREGNANEDIOL GLUCURONIDE AND OTHER HORMONES AND ANALYTES | May 2021 | September 2022 | Allow | 17 | 1 | 2 | Yes | No |
| 17315894 | Method of Improving Liquid Sample Flow in Assay Device | May 2021 | September 2025 | Allow | 52 | 0 | 0 | No | No |
| 17225605 | METHODS AND DEVICES FOR DETECTING MxA IN A SAMPLE ON A SAMPLE ANAYSIS DEVICE | April 2021 | March 2026 | Allow | 59 | 1 | 0 | No | No |
| 17217518 | METHODS FOR CHARACTERIZING LOW-ABUNDANCE HOST CELL PROTEINS | March 2021 | January 2024 | Allow | 34 | 2 | 0 | Yes | No |
| 17181127 | MANIPULATION OF SAMPLE DROPLETS WITH AN ELECTRODE SYSTEM | February 2021 | July 2025 | Allow | 52 | 0 | 0 | No | No |
| 17268799 | ENHANCED, RAPID, HOMOGENEOUS, CELL STAINING AND ASSAY | February 2021 | September 2023 | Allow | 31 | 2 | 1 | Yes | No |
| 17164996 | PORTABLE CLINICAL ANALYSIS SYSTEM FOR IMMUNOMETRIC MEASUREMENT | February 2021 | February 2026 | Allow | 60 | 1 | 0 | No | No |
| 17165392 | HOLLOW POLYMER FIBER OPTIC SYSTEM FOR SINGLE ANALYTE AND MULTIPLEXED ANALYTE DETECTION | February 2021 | June 2025 | Allow | 52 | 0 | 0 | No | No |
| 17264281 | Chelator-Coated Field Effect Transistor and Devices and Methods Using Same | January 2021 | July 2024 | Allow | 41 | 1 | 1 | No | No |
| 17152513 | POINT-OF-COLLECTION GRAPHENE-BASED TOXICOLOGY SENSOR | January 2021 | March 2025 | Allow | 50 | 2 | 1 | Yes | No |
| 17148748 | COMPOSITIONS AND METHODS FOR STUDYING DRUG METABOLISM | January 2021 | August 2025 | Allow | 55 | 3 | 1 | No | No |
| 17255258 | ISOLATING AND ANALYZING RARE BRAIN-DERIVED CELLS AND PARTICLES | December 2020 | October 2025 | Abandon | 58 | 2 | 0 | No | No |
| 17123995 | SYSTEMS, DEVICES, AND METHODS FOR AMPLIFYING SIGNALS OF A LATERAL FLOW ASSAY | December 2020 | March 2026 | Allow | 60 | 1 | 1 | No | No |
| 17055835 | ASSESSING RESPONSIVENESS OF RHEUMATOID ARTHRITIS PATIENTS TO BIOLOGICAL TREATMENT | November 2020 | December 2025 | Allow | 60 | 1 | 2 | No | No |
| 17094212 | SENSING METHOD OF BIOPARTICLE POSITIONING AND BIOPARTICLE POSITIONING SENSING SYSTEM | November 2020 | October 2024 | Allow | 47 | 1 | 1 | No | No |
| 17069591 | IMMUNOASSAY WITH ENHANCED SENSITIVITY | October 2020 | May 2025 | Allow | 55 | 0 | 0 | No | No |
| 17044059 | QUANTUM DOT BEAD HAVING MULTIFUNCTIONAL LIGAND, AND TARGET ANTIGEN DETECTION METHOD AND BIO-DIAGNOSTIC APPARATUS USING SAME | September 2020 | January 2025 | Abandon | 51 | 1 | 2 | No | No |
| 17037162 | METHOD AND SYSTEM FOR DETECTING ANALYTE OF INTEREST USING MAGNETIC FIELD SENSOR AND MAGNETIC PARTICLES | September 2020 | September 2023 | Allow | 36 | 1 | 1 | No | No |
| 17029576 | METHOD AND DEVICE FOR DETERMINING BIOLOGICAL ANALYTES | September 2020 | December 2025 | Allow | 60 | 1 | 0 | No | No |
| 17027503 | LATERAL FLOW IMMUNOASSAYS FOR THE DETECTION OF ANTIBODIES AGAINST BIOLOGICAL DRUGS | September 2020 | August 2025 | Allow | 59 | 1 | 0 | Yes | No |
| 17022942 | LC-MS METHODS FOR ANTIBODY ISOTYPING AND QUANTIFICATION | September 2020 | January 2025 | Allow | 52 | 2 | 1 | No | No |
| 17022039 | Methods and Compositions for Amplified Electrochemiluminescence Detection Assays | September 2020 | September 2025 | Allow | 60 | 1 | 0 | Yes | No |
| 17000707 | ASSAY TEST STRIPS WITH MULTIPLE LABELS AND READING SAME | August 2020 | November 2025 | Abandon | 60 | 1 | 0 | No | No |
| 16999598 | SYSTEM FOR SINGLE-MOLECULE ISOLATION FOR CELL POPULATIONS AND SINGLE CELLS, AND METHODS AND USES THEREOF | August 2020 | February 2024 | Allow | 41 | 1 | 1 | Yes | No |
| 16991111 | Dual channel immuno-quantitative test strip of Zearalenone-Deoxynivalenol | August 2020 | February 2024 | Abandon | 42 | 2 | 0 | Yes | No |
| 16990056 | EXTRACTION AND DETECTION OF PATHOGENS USING CARBOHYDRATE-FUNCTIONALIZED BIOSENSORS | August 2020 | February 2025 | Allow | 54 | 0 | 0 | No | No |
| 16941128 | Multi-Mode Separation for Target Detection and Cell Growth Monitoring | July 2020 | July 2025 | Allow | 60 | 0 | 1 | No | No |
| 16933765 | SYSTEMS AND METHODS FOR FABRICATING AN INDIUM OXIDE FIELD-EFFECT TRANSISTOR | July 2020 | September 2025 | Abandon | 60 | 3 | 0 | Yes | No |
| 16930664 | DEVICES, KITS, AND METHODS FOR LABEL-FREE FOCUSING AND/OR SEPARATION OF SUB-MICRON PARTICLES | July 2020 | July 2023 | Allow | 36 | 2 | 1 | Yes | No |
| 16910148 | METHOD OF DETECTING OR QUANTIFYING DETECTION TARGET IN SPECIMEN, COMPOSITE PARTICLE, AND REAGENT | June 2020 | September 2023 | Allow | 39 | 1 | 1 | No | No |
| 16909309 | DETECTION OF CLEAVAGE ACTIVITY OF AN ENZYME | June 2020 | March 2025 | Allow | 57 | 0 | 1 | Yes | No |
| 16762662 | MICROCHIP AND DEVICE FOR QUANTITATIVE ANALYSIS OF ANTIGEN, AND METHOD FOR QUANTITATIVE ANALYSIS OF ANTIGEN USING SAME | May 2020 | April 2025 | Allow | 59 | 3 | 1 | No | No |
| 16759392 | IMMUNOCHROMATOGRAPHIC TEST STRIP | April 2020 | January 2026 | Allow | 60 | 4 | 0 | Yes | No |
| 16758163 | IMMUNODETECTION CHIP, IMMUNODETECTION DEVICE AND USING METHOD | April 2020 | January 2024 | Allow | 45 | 3 | 1 | Yes | No |
| 16850541 | Methods for Detecting Antibodies by Surface Plasmon Resonance | April 2020 | May 2024 | Allow | 49 | 2 | 1 | Yes | No |
| 16849637 | SENSORS, SYSTEMS AND METHODS FOR DETECTING ANALYTES USING SAME | April 2020 | April 2023 | Allow | 36 | 2 | 2 | Yes | No |
| 16845035 | Multiplexed Lateral Flow Assay Device | April 2020 | October 2023 | Allow | 43 | 2 | 0 | Yes | No |
| 16844463 | LATERAL FLOW IMMUNOASSAY FOR MEASURING FUNCTIONAL C1-ESTERASE INHIBITOR (C1-INH) IN PLASMA SAMPLES | April 2020 | July 2024 | Allow | 52 | 1 | 1 | Yes | No |
| 16839158 | SENSOR FOR LIQUID BIOPSY AND ITS METHOD OF MAKING, AND METHOD OF NON-INVASIVE LIQUID BIOPSY | April 2020 | July 2024 | Allow | 51 | 4 | 1 | Yes | No |
| 16831678 | Target Detection with Nanopore | March 2020 | June 2025 | Allow | 60 | 1 | 1 | No | No |
| 16822994 | PLACENTAL LIPID BILAYER FOR CELL-FREE MOLECULAR INTERACTION STUDIES | March 2020 | November 2024 | Allow | 56 | 2 | 1 | Yes | No |
| 16634315 | TIME-RESOLVED FLUORESCENCE IMMUNOCHROMATOGRAPHY KIT FOR SIMULTANEOUS DETECTION OF MIXED POLLUTANT OF AFLATOXIN AND CARBARYL, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | January 2020 | March 2025 | Allow | 60 | 2 | 0 | No | No |
| 16492303 | TIME-RESOLVED FLUORESCENCE IMMUNOCHROMATOGRAPHIC KIT FOR SIMULTANEOUS DETECTION OF MIXED CONTAMINATION OF FIVE MYCOTOXINS SUCH AS AFLATOXIN B1 AND APPLICATION THEREOF | January 2020 | November 2024 | Allow | 60 | 2 | 0 | No | No |
| 16747021 | DETECTION DEVICE AND DETECTION METHOD | January 2020 | June 2023 | Allow | 41 | 2 | 0 | No | No |
| 16631703 | METHOD FOR QUANTITATIVELY ANALYZING TARGET MATERIAL AND DEVICE FOR QUANTITATIVELY ANALYZING TARGET MATERIAL BY USING SAME | January 2020 | May 2024 | Allow | 52 | 2 | 1 | No | No |
| 16602966 | Optical biomodule for detection of diseases at an early onset | January 2020 | April 2023 | Allow | 39 | 1 | 0 | No | No |
| 16627376 | SYSTEM AND METHOD FOR DEPOSITING ANTISERA IN IMMUNOFIXATION ELECTROPHORESIS | December 2019 | January 2023 | Abandon | 36 | 2 | 0 | No | No |
| 16730660 | Containers Containing Degradable Carriers | December 2019 | December 2024 | Allow | 60 | 4 | 1 | Yes | Yes |
| 16728841 | SPECTROSCOPIC ASSAYS AND TAGGING | December 2019 | November 2025 | Abandon | 60 | 2 | 1 | No | No |
| 16626584 | IN SITU SERIAL DILUTION METHOD | December 2019 | October 2024 | Allow | 58 | 0 | 2 | No | No |
| 16700021 | Devices and Methods for Detection and Quantification of Immunological Proteins, Pathogenic and Microbial Agents and Cells | December 2019 | August 2024 | Allow | 56 | 2 | 1 | No | No |
| 16700677 | Methods for Cancer Detection with Quantum Dots | December 2019 | January 2025 | Allow | 60 | 1 | 1 | No | No |
| 16664341 | RAPID MULTIPLEX DIAGNOSTIC FOR PARKINSON'S DISEASE AND ALZHEIMER'S DISEASE | October 2019 | January 2023 | Abandon | 39 | 0 | 1 | No | No |
| 16583264 | METHOD FOR ACTIVATING AND EXPANDING ISOLATED T CELLS | September 2019 | July 2024 | Allow | 58 | 1 | 1 | No | No |
| 16582176 | EVALUATING ASSAYS WITH OPTICAL INHOMOGENEITIES | September 2019 | May 2025 | Allow | 60 | 2 | 1 | No | No |
| 16577805 | APPARATUS FOR PERFORMING CONTACTLESS OPTICALLY-INDUCED DIELECTROPHORESIS FOR SEPARATION OF CIRCULATING TUMOR CELLS | September 2019 | December 2023 | Allow | 51 | 1 | 0 | No | No |
| 16492427 | IMMUNOCHROMATOGRAPHIC TEST PIECE FOR EXTRACTING AND MEASURING SUGAR CHAIN ANTIGEN, WHICH IS CAPABLE OF CONTROLLING DEVELOPMENT OF SPECIMEN | September 2019 | October 2023 | Allow | 49 | 3 | 0 | No | No |
| 16492128 | METHOD AND APPARATUS FOR ORDERED NANOPLASMONIC SENSOR FORMATION THROUGH MICROFLUIDIC ASSEMBLY | September 2019 | June 2023 | Allow | 46 | 2 | 1 | Yes | No |
| 16560401 | SYSTEM AND METHOD FOR DIAGNOSING SENSOR PERFORMANCE USING ANALYTE-INDEPENDENT RATIOMETRIC SIGNALS | September 2019 | January 2024 | Abandon | 52 | 1 | 0 | No | No |
| 16544554 | METHOD AND APPARATUS FOR A PREGNANEDIOL URINE ASSAY | August 2019 | November 2024 | Abandon | 60 | 2 | 1 | No | No |
| 16537833 | METHODS FOR INCREASING THE MOLECULAR SPECIFICITY OF A NANOSENSOR | August 2019 | December 2025 | Allow | 60 | 2 | 1 | Yes | Yes |
| 16484678 | QMAX ASSAYS AND APPLICATIONS | August 2019 | February 2024 | Allow | 55 | 2 | 1 | Yes | No |
| 16532855 | Method and Device for Combined Detection of Viral and Bacterial Infections | August 2019 | August 2023 | Abandon | 48 | 0 | 1 | No | No |
| 16483080 | Device and Determination System Using Same | August 2019 | November 2022 | Allow | 40 | 2 | 1 | Yes | No |
| 16530040 | APPARATUSES AND METHODS FOR DETECTING MOLECULES AND BINDING ENERGY | August 2019 | December 2023 | Allow | 52 | 2 | 0 | Yes | No |
| 16512532 | SPECTRAL SHIFTS AND MODIFICATIONS IN METAL-ENHANCED FLUORESCENCE, PHOSPHORESCENCE AND ALPHA-FLUORESCENCE | July 2019 | November 2023 | Allow | 52 | 1 | 1 | Yes | No |
| 16474707 | METHOD OF FUNCTIONALIZATION OF A GATE ELECTRODE OF A FIELD-EFFECT TRANSISTOR SENSOR | June 2019 | March 2026 | Allow | 60 | 4 | 2 | Yes | No |
| 16473835 | METHOD OF STORING LATEX PARTICLE DISPERSION LIQUID | June 2019 | October 2024 | Allow | 60 | 2 | 1 | Yes | No |
| 16428961 | Multiplexed Lateral Flow Assay Device | May 2019 | August 2022 | Allow | 38 | 1 | 1 | Yes | No |
| 16464792 | LIQUID IMMERSION MICRO-CHANNEL MEASUREMENT DEVICE AND MEASUREMENT METHOD WHICH ARE BASED ON TRAPEZOIDAL INCIDENT STRUCTURE PRISM INCIDENT-TYPE SILICON | May 2019 | March 2023 | Allow | 46 | 1 | 0 | No | No |
| 16423787 | METHODS AND APPARATUS FOR SIMULTANEOUSLY DETECTING A LARGE RANGE OF PROTEIN CONCENTRATIONS | May 2019 | January 2023 | Allow | 43 | 1 | 1 | Yes | No |
| 16422178 | SYSTEM AND METHOD FOR DETECTION OF DUST MITE ANTIGENS | May 2019 | March 2023 | Allow | 46 | 1 | 1 | No | No |
| 16420412 | Micro-Fluidic System Using Micro-Apertures for High Throughput Detection of Cells | May 2019 | June 2022 | Allow | 37 | 1 | 0 | Yes | No |
| 16417599 | Celocoxib Binding Antibodies and Uses Thereof | May 2019 | March 2023 | Abandon | 46 | 1 | 0 | No | No |
| 16401418 | CATALYTIC PARTICLES FOR SIGNAL ENHANCEMENT FOR LATERAL FLOW IMMUNOASSAYS | May 2019 | October 2024 | Allow | 60 | 3 | 1 | No | No |
| 16389852 | DETECTION OF TARGETS | April 2019 | March 2024 | Allow | 59 | 3 | 1 | No | No |
| 16374713 | METHODS FOR AFFINITY-BASED NON-ANTIBODY CAPTURE AND PURIFICATION OF EXTRACELLULAR VESICLES | April 2019 | December 2024 | Allow | 60 | 4 | 1 | Yes | No |
| 16298322 | Incubation trough and incubation tray with a plurality of incubation troughs | March 2019 | September 2022 | Allow | 43 | 1 | 1 | No | No |
| 16329853 | STEPPED MERGED INJECTION FOR SURFACE PLASMON RESONANCE ASSAYS | March 2019 | February 2025 | Allow | 60 | 5 | 1 | Yes | No |
| 16315877 | HAEMOGLOBIN TEST KIT | January 2019 | March 2023 | Abandon | 50 | 1 | 0 | No | No |
| 16229487 | BIOLOGICAL MEMBRANE-BASED SENSOR | December 2018 | October 2022 | Allow | 45 | 2 | 1 | Yes | No |
| 16308219 | DETECTING AN ANALYTE | December 2018 | September 2022 | Allow | 45 | 2 | 1 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner CHIN, CHRISTOPHER L.
With a 33.3% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 30.4% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner CHIN, CHRISTOPHER L works in Art Unit 1677 and has examined 604 patent applications in our dataset. With an allowance rate of 88.4%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 41 months.
Examiner CHIN, CHRISTOPHER L's allowance rate of 88.4% places them in the 69% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.
On average, applications examined by CHIN, CHRISTOPHER L receive 1.64 office actions before reaching final disposition. This places the examiner in the 33% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.
The median time to disposition (half-life) for applications examined by CHIN, CHRISTOPHER L is 41 months. This places the examiner in the 20% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +11.0% benefit to allowance rate for applications examined by CHIN, CHRISTOPHER L. This interview benefit is in the 45% percentile among all examiners. Recommendation: Interviews provide a below-average benefit with this examiner.
When applicants file an RCE with this examiner, 28.5% of applications are subsequently allowed. This success rate is in the 52% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.
This examiner enters after-final amendments leading to allowance in 55.2% of cases where such amendments are filed. This entry rate is in the 81% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.
When applicants request a pre-appeal conference (PAC) with this examiner, 66.7% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 52% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.
This examiner withdraws rejections or reopens prosecution in 87.5% of appeals filed. This is in the 80% percentile among all examiners. Of these withdrawals, 71.4% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.
When applicants file petitions regarding this examiner's actions, 68.9% are granted (fully or in part). This grant rate is in the 76% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 8.6% of allowed cases (in the 92% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.4% of allowed cases (in the 54% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.